Pulmonary artery enlargement in schistosomiasis associated pulmonary arterial hypertension

Carregando...
Imagem de Miniatura
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Citação
BMC PULMONARY MEDICINE, v.15, article ID 118, 5p, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Schistosomiasis associated pulmonary arterial hypertension (Sch-PAH) might represent the most prevalent form of PAH worldwide. In Sch-PAH, the presence of aneurismal dilation of the pulmonary artery has been described, although it is still a matter of debate whether on average the pulmonary artery is more enlarged in Sc-PAH than IPAH. Methods: We retrospectively evaluated patients with IPAH (n = 25) and Sch-PAH (n = 22) who underwent computed tomography pulmonary angiogram and right heart catheterization. Results: Sch-PAH patients were older and presented less severe hemodynamic profiles. Main pulmonary artery diameter (MPAD) was greater in Sch-PAH than IPAH (4.5 +/- 1.8 vs 3.7 +/- 1.1 cm, p = 0.018). For the same level of mean pulmonary artery pressure, the MPAD in Sch-PAH was 0.89 cm larger than in IPAH (Covariance model p = 0.02). Conclusion: This study demonstrated that pulmonary artery enlargement is more pronounced in Sch-PAH than IPAH, independently of mean pulmonary artery pressure level, suggesting that this is more likely a feature of Sch-PAH.
Palavras-chave
Schistosomiasis, Idiopathic pulmonary arterial hypertension, Pulmonary artery, Hemodynamics, Computed tomography
Referências
  1. Alves JL, 2015, CHEST, V147, P495, DOI 10.1378/chest.14-1036
  2. Andrade Z A, 1983, Mem Inst Oswaldo Cruz, V78, P285
  3. Gavilanes F, 2014, J BRAS PNEUMOL, V40, P609, DOI 10.1590/S1806-37132014000600004
  4. Badagliacca R, 2012, CARDIOLOGY, V121, P76, DOI 10.1159/000336172
  5. Piveta RB, 2012, EUR HEART J, V33, P1159, DOI 10.1093/eurheartj/ehs024
  6. Simonneau G, 2013, J AM COLL CARDIOL, V62, pD34, DOI 10.1016/j.jacc.2013.10.029
  7. Kolosionek E, 2011, CLIN MICROBIOL INFEC, V17, P15, DOI 10.1111/j.1469-0691.2010.03308.x
  8. Boerrigter B, 2010, CHEST, V138, P1395, DOI [10.1378/chest.10-0363, 10.1378/chest.10.0363]
  9. Lapa M, 2009, CIRCULATION, V119, P1518, DOI 10.1161/CIRCULATIONAHA.108.803221
  10. Zylkowska J, 2012, CHEST, V142, P1406, DOI 10.1378/chest.11-2794
  11. Fernandes CJCD, 2010, J AM COLL CARDIOL, V56, P715, DOI 10.1016/j.jacc.2010.03.065
  12. Petrovic V, 2011, CAN RESPIR J, V18, pE50
  13. Perloff JK, 2003, AM J CARDIOL, V92, P182, DOI 10.1016/S0002-9149(03)00535-6
  14. Dorfmuller P, 2003, EUR RESPIR J, V22, P358, DOI 10.1183/09031936.03.00038903
  15. Mauad T, 2014, J INFECTION, V68, P90, DOI 10.1016/j.jinf.2013.08.004
  16. Fernandes CJCS, 2012, CHEST, V141, P923, DOI 10.1378/chest.11-0483
  17. Dos CJC, 2011, EXPERT REV RESP MED, V5, P675, DOI 10.1586/ERS.11.58
  18. Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jaac.2004.02.029
  19. Lapa M, 2014, LUNG, V192, P981, DOI 10.1007/s00408-014-9643-0